Results 221 to 230 of about 188,535 (344)

A Metabolomic Signature Predicts Gout Flare Clinical Outcome Associated With Colchicine Prophylaxis

Arthritis &Rheumatology, EarlyView.
Objective This study investigated that serum metabolomics, before urate‐lowering therapy (ULT) initiation, could serve as a biomarker for responsiveness to colchicine prophylaxis in patients with gout commencing treat‐to‐target ULT. Methods We studied a multicenter prospective cohort (n = 409) initiating treat‐to‐target ULT plus colchicine prophylaxis.
Wenyan Sun, Lingfang Xu, Haibing Chen, Mingshu Sun, Zhiqiang Li, Rui Li, Lidan Ma, Hui Zhang, Aichang Ji, Yuwei He, Na Wu, Le Yan, Robert Terkeltaub, Changgui Li   +13 more
wiley   +1 more source

NAFLD‐related hepatocellular carcinoma: The growing challenge

Hepatology, EarlyView., 2022
Risk and protective factors for NAFLD‐related hepatocellular carcinoma Abstract Hepatocellular carcinoma (HCC) is a common cause of cancer‐related mortality and morbidity worldwide. With the obesity pandemic, NAFLD‐related HCC is contributing to the burden of disease exponentially.
Pir Ahmad Shah, Rashmee Patil, Stephen A. Harrison   +2 more
wiley   +1 more source

Association Between HLA Polymorphisms and Non-Alcoholic Fatty Liver Disease in Patients with Rheumatoid Arthritis: An Observational Study. [PDF]

Diseases
Zekić T, Katalinić N, Blažić F, Starčević Čizmarević N, Čubranić A.   +4 more
europepmc   +1 more source

The Metabolic Triad-intermittent Fasting as a Shared Therapeutic Avenue for Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Gastroesophageal Reflux Disease

Sawera Haider
openalex   +1 more source

APPLICATION OF BETARGIN IN THE TREATMENT OF STABLE CORONARY HEART DISEASE AND NON-ALCOHOLIC FATTY LIVER DISEASE

, 2018
Yu. I. Manusha, Yu. M. Kazakov, Mamontova Tv, O. A. Shlykova, Наталія Ігорівна Чекаліна   +4 more
openalex   +1 more source

Computed tomography findings of portal hypertension in non-alcoholic fatty liver disease

, 2022
Gayatri Patil, Amolkumar Patil, Madan Manmohan   +2 more
openalex   +2 more sources

Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks

British Journal of Clinical Pharmacology, EarlyView.
The relationship between cannabinoids and mental health has become a major focus of scientific inquiry and public discourse. Cannabinoids are diverse chemical compounds from the Cannabis species that have been explored for their therapeutic applications in treating chronic pain, psychiatric and neurological conditions, such as depression, schizophrenia,
Paraskevi Papakyriakopoulou, Georgia Valsami, Georgios Ismailos   +2 more
wiley   +1 more source

SIRT1-mediated FABP4 destabilization attenuates fibrosis and ferroptosis in non-alcoholic fatty liver disease. [PDF]

Clin Exp Med
Qiu H, Chen K, Qiu Y, Yang Y, Wang T, Wang W, Jiang L.   +6 more
europepmc   +1 more source

Relationship of Sex Hormones with Obesity and Non-alcoholic Fatty Liver Disease in Boys with Gynecomastia

, 2023
Deniz Özalp Kızılay, Hale Tuhan, Eren İsmailoğlu, Şebnem Ateş, Aslı Süner   +4 more
openalex   +1 more source

Effect of carbamazepine on the pharmacokinetics of vepdegestrant, a PROteolysis TArgeting Chimera estrogen receptor degrader, in healthy adults

British Journal of Clinical Pharmacology, EarlyView.
Aim To evaluate the effects of carbamazepine, a strong cytochrome P450 (CYP)3A4 inducer, on the pharmacokinetics and safety of vepdegestrant, a PROteolysis TArgeting Chimera estrogen receptor degrader. Methods This was a phase 1, open‐label, fixed‐sequence, two‐period study in healthy adult participants.
Hechuan Wang, Jennifer A. Winton, Kyle T. Matschke, Alexandre Stouffs, Kimberly C. Lee, Yuanyuan Zhang, Wenlian Qiao, Weiwei Tan   +7 more
wiley   +1 more source